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SpainAbstractSixty-four patients with periprosthetic infection within 3 months of index arthroplasty, of whom 39 underwent debridement with prosthesis
retention and antibiotherapy (DPRA), and 25 underwent two-stage revision (2SR), were compared regarding control of infection and
functional outcomes by use of Knee Society scores. Failure was deﬁned as the need for subsequent surgery to control infection. The
failure rate after DPRA was 61.5%, and that after 2SR was 12.0% (p 0.001). The failure risk was not signiﬁcantly associated with the
duration of symptoms (4 weeks). The only predictor of failure was isolation of Staphylococcus aureus or Staphylococcus epidermidis.
Treatment with 2SR required fewer surgical operations, a shorter duration of hospitalization, and a shorter duration of treatment. All
patients who required a second debridement ultimately underwent prosthesis removal. The functional outcome was signiﬁcantly better
for 2SR at the last follow-up.
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E-mail: lizaur1@telefonica.netIntroductionCurrently, two-stage revision (2SR) with antibiotic-laden spacer
placement is considered to be the reference standard for
treatment of periprosthetic knee infection [1]. However, the
procedure has some disadvantages, such as a minimum of two
surgical operations, disability during the interval between
stages, and related costs [2]. As a result, debridement with
prosthesis retention and antibiotherapy (DPRA) has beenClinical Microbiology and Infection © 2015 European Society of Cconsidered to be an attractive alternative for many surgeons
and patients [3–5]. High failure rates in controlling infection
with DPRA have been reported in the last decade [6,7],
although recent studies on periprosthetic joint infections
treated with DPRA have reported successful results in 56% of
staphylococcal infections [8] and in 68% of Gram-negative in-
fections [9]. Unsuccessful results were mainly associated with
organism type and the timing relative to total knee arthroplasty
(TKA) [10]. Furthermore, there is a lack of studies with
consistent evidence in the literature [6,11]. We have found only
three studies comparing DPRA with 2SR [12–14].
The main purpose of this study was to compare the effec-
tiveness in controlling periprosthetic knee infection within
3 months of index arthroplasty between 2SR and DPRA. In
addition, this study was designed to examine the inﬂuence of
several factors on the risk of treatment failure, and to compare
the functional outcomes.Clin Microbiol Infect 2015; 21: 851.e11–851.e17
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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851.e12 Clinical Microbiology and Infection, Volume 21 Number 9, September 2015 CMIMaterials and methodsThe study was approved by our Institutional Review Board
(Elda University Hospital), and informed consent was not
required. The study was a retrospective, comparative case–
control study, with patients being prospectively followed. All
consecutive deep periprosthetic knee infections treated be-
tween 2000 and 2011 were eligible for study. Between 2000
and 2006, the standardized protocol at our department
included DPRA for infections that occurred within 3 months
after TKA, and 2SR for those diagnosed later than this. In the
light of new evidence, since 2007 2SR has also been applied for
deep infections occurring within 3 months. Patients with peri-
prosthetic infection after TKA were identiﬁed in our depart-
mental database. This database collects prospective data and
outcomes routinely and systematically for all patients who un-
dergo joint replacement. The inclusion criterion was onset of
symptoms within 3 months after TKA. A minimum post-
operative follow-up of 3 years was required to assess out-
comes. The exclusion criteria were a prior history of
osteoarticular infection at any location, and patients being
initially treated at an outside centre.
Deﬁnitions
Periprosthetic infection was deﬁned by the presence of any one of
the following four parameters [15]: (a) sinus tract; (b) growth of
the same organism from at least two cultures; (c) purulence
around the prosthesis during surgery; and (d) the presence of
several of the following parameters: (i) isolation of a organism in
one culture, (ii) typical clinical symptoms and signs, (iii) an elevated
erythrocyte sedimentation rate of >30 mm/h and a C-reactive
protein level of >10mg/L, and (iv) an elevated synovial white blood
cell count of >2000/μL and a neutrophil differential count of >65%.
The primary outcome variable was success or failure of the
procedure. Failure was deﬁned as the need for a subsequent
surgical procedure to treat the infection by the same or other
organism. Repeated DRPA was considered to be failure.
Therapeutic protocol
All operations were performed under spinal anaesthesia in an
operating room with laminar ﬂow. Previous incisions and sur-
gical approaches were always used. In both groups, the index
TKA used was a modular posterior cruciate ligament-retaining
design (Multigen System; Lima, San Daniele, Italy) with hybrid
ﬁxation. The tibial cement was gentamicin loaded (Ceraﬁxgenta,
Ceraver, France). Standard antibiotic prophylaxis with ﬁrst-
generation cephalosporin for 24 h was used in all patients.
In the DRPA group, the surgical procedure included open
arthrotomy, obtaining ﬁve samples for microbiological analysis,Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectimplant retention after checking of its stability, exchange of the
polyethylene insert, thorough debridement, and irrigation with
sterile normal saline.
In the 2SR group, the ﬁrst stage included obtaining ﬁve cul-
ture samples, removing all prosthetic components, debride-
ment, and irrigation. An articulating antibiotic-loaded cement
spacer was inserted. For the spacer, 1 g of gentamicin was
mixed with 40 g of cement. TKA reimplantation was performed
when the infection was judged to be under control, on the basis
of clinical ﬁndings, negative aspiration results, and normalization
of inﬂammatory markers. The minimum time interval between
stages was 4 months. This second stage consisted of obtaining
ﬁve culture samples again, removing the spacer, new debride-
ment and irrigation, and reimplantation with a similar cemented
posterior-stabilized primary prosthesis with extension stems.
All fusion was performed in 2 stages, and cemented intra-
medullary nail (Endo-Model Link; Waldemar Link, Hamburg,
Germany) was used.
The postoperative regimen was similar in both groups. After
surgery to control infection, broad-spectrum intravenous
antibiotherapy was started, and this was maintained until cul-
ture results were obtained. Then, intravenous speciﬁc antibi-
otics were adjusted, and maintained during hospitalization for at
least 3 weeks, followed after discharge by oral antibiotherapy
for approximately 3 months.
Evaluations
Prospective clinical and radiological evaluations were per-
formed preoperatively and postoperatively at 1, 3, 6 and
12 months, and then yearly for at least 3 years.
Knee Society scores (KSSs) [16] were used for clinical
evaluations. Patient comorbidity at the time of the index TKA
was assessed according to the American Society of Anesthesi-
ologists [17] score and Charlson index [18]. Infection risk was
assessed according to the McPherson criteria [19]. Erythrocyte
sedimentation rate and C-reactive protein were monitored at
each postoperative visit. In 2SR, a joint aspiration was per-
formed at least 3 weeks prior to reimplantation.
Radiological evaluation including anteroposterior, lateral and
skyline views was performed for positioning of the compo-
nents, and the presence and location of radiolucent lines, ac-
cording to the Knee Society criteria [20]. Deﬁnitive loosening
was deﬁned as continuous or progressive radiolucent lines or as
migration of any component.
Statistical analysis
Statistical analyses were conducted with SPSS software, version
15.0 (SPSS, Chicago, Il, USA). A p-value of <0.05 was consid-
ered to be signiﬁcant in all analyses. To determine a normal
distribution, a Kolmogorov–Smirnov test was used. Forious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e11–851.e17
CMI Lizaur-Utrilla et al. Debridement with prosthesis retention and antibiotherapy 851.e13comparison between groups, we performed univariate analysis
on categorical variables with the chi-square test for parametric
data or the Mantel–Haenszel test for non-parametric data, and
the t-test or Mann–Whitney U-test on continuous variables.
For comparison between preoperative and postoperative data,
we used the paired t-test or Wilcoxon signed rank test. Sub-
sequently, multivariate analysis was conducted with linear
regression to identify the independent predictors of treatment
failure. Because of the high prevalence of staphylococci in this
study, the causal pathogen variable was divided into two cate-
gories, i.e. the main staphylococci (which included Staphylo-
coccus aureus and Staphylococcus epidermidis) and others. ORs
and the 95% CIs were obtained. The Kaplan–Meier test was
used for cumulative arthroplasty survival analysis, and the log-
rank test was used to compare survival curves between groups.ResultsThe sample consisted of 64 patients with periprosthetic infec-
tion; 39 underwent DPRA, and 25 underwent 2SR. Four patients
in the DPRA group and three in the 2SR group died at 5–10
postoperative years, all of them from causes unrelated to the
arthroplasty (cancer and heart disease). Their data at the last
follow-up were included, because they had completed the 3-year
minimum prospective follow-up required in this study. There
were no other losses to follow-up. The mean postoperative
follow-up was 4.0 years (range, 3–6.2 years) in the DPRA group
and 4.1 years (range, 3–6.1 years) in the 2SR group.
The two groups were comparable regarding preoperative
data (Table 1), onset of symptoms (p 0.305), and onset of
treatment (time from the index TKA to initial surgery for
infection control) (p 0.228). In the 2SR group, the mean time
interval between stages was 5.3 months (range, 4–6 months).
In all patients, empirical antibiotherapy was used until culture
results were obtained; this consisted of teicoplanin (400 mgTABLE 1. Demographic and perioperative data in both groups
DPRA (n [ 39) 2SR (n [ 25) p
Women/men (n) 24/15 19/6 0.177
Age (years), mean (range) 71.8 (51–82) 73.8 (65–82) 0.274
BMI (kg/m2), mean (range) 27.2 (24.0–31.5) 27.7 (24.6–34.7) 0.383
ASA I– II/III– IV (n) 29/10 18/7 0.284
Comorbidities (n), mean
(range)
1.1 (0–4) 1.7 (0–4) 0.056
Charlson 0/I– II/>II (n) 11/25/3 5/13/7 0.090
McPherson A/B/C (n) 24/15/0 10/15/0 0.061
TKA primary/revision (n) 33/6 19/6 0.294
Symptom onset (days),
mean (range)
23.9 (7–35) 27.6 (4–65) 0.305
Treatment onset (days),
mean (range)
25.0 (7–35) 29.4 (8–77) 0.228
ASA, American Society of Anesthesiologists; BMI, body mass index; DPRA,
debridement with prosthesis retention and antibiotherapy; 2SR, two-stage revision;
TKA, total knee arthroplasty.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infeevery 12 h, intravenous) or a combination of ciproﬂoxacin (400
mg every 12 h, intravenous) and rifampicin (600 mg daily, oral).
There was no signiﬁcant difference in empirical treatment be-
tween the groups (p 0.829). After the ﬁrst operation to control
infection, the speciﬁc antibiotics administered in the 2SR group
were ciproﬂoxacin–rifampicin in 14 patients and intravenous
teicoplanin in 11 patients, and the speciﬁc antibiotics adminis-
tered in the DPRA group were ciproﬂoxacin–rifampicin in 23
patients, intravenous teicoplanin in 11 patients, intravenous
cefazolin (1 g every 8 h) in three patients, and intravenous
amoxycillin–clavulanate (1 g every 8 h) in two patients. The
mean durations of intravenous treatment in the two groups
were 22.5 days in 2SR group and 23.8 days in DPRA group (p
0.674). The oral antibiotherapy consisted of ciproﬂoxacin (750
mg every 12 h) in 14 patients and co-trimoxazole (800/160 mg
every 12 h) in 11 patients in the 2SR group, and in 28 and 11
patients, respectively, in the DPRA group. The mean durations
of oral treatment in the two groups were 61.3 days in 2SR
group and 58.6 days in DPRA group (p 0.714). There was no
signiﬁcant difference in mean duration of antibiotic treatment
between failure cases (81.7 days) and success cases (83.6 days)
in the 2SR group (p 0.140) or in the DPRA group (83.1 days and
80.6 days, respectively) (p 0.194).
Failure rate
In the DPRA group, there were 15 successes (38.5%) and 24
failures (61.5%) (OR 2.2, 95% CI 1.4–3.3), and in the 2SR group
there were 22 successes (80.0%) and three failures (12.0%) (OR
0.2, 95% CI 0.01–0.5) (p 0.001). The 6-year cumulative
infection-free survival rates were 38.4% (95% CI 23.1–53.0) in
the DPRA group, and 88.0% (95% CI 75.2–100) in the 2SR
group (p 0.001).
There were no signiﬁcant differences in failure rate related to
the speciﬁc antibiotherapy (p 0.075) or mean duration of antibi-
otic treatment (p 0.516) between the two groups. The adminis-
tration of rifampicin did not inﬂuence the failure rate (p 0.181).
Re-interventions
Aseconddebridementwas performed in the24patientswith failed
DPRA, to control infection; this failed in all them. Subsequently,
three of these underwent two-stage arthrodesis, resulting in suc-
cessful infection control. The remaining 21 patients underwent
2SR, which was successful in 13 patients and unsuccessful in eight
patients. These eight patients required an additional two-stage
arthrodesis, which was successful in controlling infection in
seven patients; the other patient required chronic antibiotic sup-
pression. Thus, the mean number of operations required for
infection control in the DPRA group was 3.2 (range, 1–6).
In the 2SR group, a subsequent 2SR was performed in two
patients with failure, and was successful in both. The remainingctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e11–851.e17
TABLE 2. Perioperative outcomes in both groups
DPRA 2SR p
Operations (n), mean (range) 3.2 (1–6) 2.2 (2–4) 0.015
Blood transfusion (n), mean (range) 0.9 (0–4) 1.5 (0–6) 0.119
Cumulative stay (days), mean (range) 54.2 (10–119) 41.3 (21–80) 0.039
Treatment duration (days), mean
(range)
241 (5–900) 163 (120–305) 0.045
DPRA, debridement with prosthesis retention and antibiotherapy; 2SR, two-stage
revision.
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result, and required chronic antibiotic suppression. Thus, the
mean number of operations required for infection control in
the 2SR group was 2.2 (range, 2–4) (p 0.015).
Overall, the rate of effectiveness of 2SR as initial treatment
to control infection was 88.0%, and for 2SR performed after
failed DPRA it was 66.7% (p 0.010).
The mean cumulative blood transfusion in all operations was
not signiﬁcantly different between the groups (p 0.119), but
there were signiﬁcant differences (Table 2) in the mean cu-
mulative hospital stay required to control infection (p 0.039)
and in mean overall treatment duration (p 0.045), deﬁned as the
time from initial surgery to control infection to the last oper-
ation performed.
Microbiology
In the DPRA group, S. aureus was isolated from 16 knees
(41.0%) and S. epidermidis from 11 knees (28.2%). Another nine
knees had polymicrobial infections, and, in all of these cases, a
staphylococcal organism was isolated together with other or-
ganisms. From the remaining knees, a variety of microorganisms
were isolated (Staphylococcus lugdunensis, Staphylococcus hae-
molyticus, Anaerococcus, Streptococcus, Enterococcus faecalis,TABLE 3. Predictors for failure after debridement with prosthesis
Patients (n [ 39) Failures (n [ 2
Gender (n)
Male 15 9
Female 24 15
Age (years), mean (SD) 70.4 (8.1) 72.7 (8.1)
BMI (kg/m2), mean (SD) 27.1 (1.8) 27.3 (1.5)
ASA (n)
I– II 29 16
III– IV 10 8
Charlson index (n)
Low 11 5
Medium/high 28 19
McPherson (n)
Type A 24 13
Type B 15 11
Index TKA (n)
Primary 33 19
Revision 6 5
Symptom onset (days), mean (SD) 24.2 (7.3) 23.7 (7.9)
Organism (n)
Other 12 4
Staphylococcus 27 20
ASA, American Society of Anesthesiologists; BMI, body mass index; SD, standard deviation;
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectPropionibacterium acnes, Escherichia coli, and Enterobacter
cloacae). Culture was negative in two knees.
In the 2SR group, S. aureus was isolated from 12 knees
(48.0%) and S. epidermidis from seven knees (28.0%). Either
microorganism was present in all three failures after 2SR.
Another three knees had polymicrobial infections, and, in all of
these cases, a staphylococcal organism was isolated together
with other organisms. From the remaining knees, a variety of
microorganisms were isolated (Streptococcus salivarius, Staphy-
lococcus capitis, Streptococcus, E. faecalis, Corynebacterium,
Escherichia coli, Enterobacter cloacae, and Pseudomonas aerugi-
nosa). Culture was negative in one knee.
The prevalence of resistant or susceptible Staphylococcus
species was similar in both treatment groups (p 0.564).
Failure risk factors
Predictors of failure after DPRA are shown in Table 3. Both
univariate and multivariate regression analyses revealed that the
only signiﬁcant predictor was the Staphylococcus category
(which included S. aureus and S. epidermidis) (OR 2.0, 95% CI
1.1–7.4; p 0.043). There was no signiﬁcant difference between
the two Staphylococcus categories (p 0.496). In the 2SR group
(Table 4), univariate and multivariate analyses failed to show any
signiﬁcant predictor of treatment failure. In both groups, there
was no signiﬁcant association with failure in terms of whether
the initial surgical procedure to control infection was per-
formed within 1 month of the index TKA or at >1 month after
the index TKA (DPRA, p 0.129; 2SR, p 0.930).
Functional outcomes
Preoperative and postoperative functional outcomes are shown
in Table 5. There were no signiﬁcant preoperative differences
between the groups. The KSS signiﬁcantly improved at lastretention and antibiotherapy
4) Univariate p Adjusted OR (95% CI) Adjusted p
0.570 0.775
1 (reference)
1.4 (0.1–20.5)
0.385 1.0 (0.7–1.4) 0.809
0.641 1.2 (0.6–2.6) 0.499
0.155 0.553
1 (reference)
0.3 (0.08–13.1)
0.176 0.346
1 (reference)
0.1 (0.01–11.0)
0.196 0.274
1 (reference)
0.04 (0.01–11.5)
0.237 0.909
1 (reference)
1.2 (0.02–78.1)
0.861 0.7 (0.5–1.0) 0.129
0.020 0.043
1 (reference)
2.0 (0.1–7.4)
TKA, total knee arthroplasty.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e11–851.e17
TABLE 4. Predictors for failure after two-stage revision
Patients (n [ 25) Failures (n [ 3) Univariate p Adjusted OR (95% CI) Adjusted p
Gender (n) 0.421 0.686
Male 6 0 1 (reference)
Female 19 3 0.6 (0.05–6.5)
Age (years), mean (SD) 73.3 (4.5) 77.0 (1.0) 0.189 0.9 (0.7–1.2) 0.967
BMI (kg/m2), mean (SD) 27.9 (2.4) 25.7 (0.9) 0.138 1.0 (0.5–2.3) 0.853
ASA (n) 0.180 0.130
I– II 18 1 1 (reference)
III– IV 7 2 0.1 (0.01–1.7)
Charlson index (n) 0.496 0.840
Low 5 0 1 (reference)
Medium/high 20 3 0.6 (0.01–35.7)
McPherson (n) 0.243 0.385
Type A 9 0 1 (reference)
Type B 16 3 0.4 (0.05–0.4)
Index TKA (n) 0.579 0.751
Primary 19 2 1 (reference)
Revision 6 1 0.6 (0.06–0.3)
Symptom onset (days), mean (SD) 29.6 (21.1) 13.0 (8.1) 0.196 0.9 (0.7–0.2) 0.930
Organism (n) 0.421 0.125
Other 6 0 1 (reference)
Staphylococcus 19 3 0.2 (0.01–2.5)
ASA, American Society of Anesthesiologists; BMI, body mass index; SD, standard deviation; TKA, total knee arthroplasty.
CMI Lizaur-Utrilla et al. Debridement with prosthesis retention and antibiotherapy 851.e15follow-up in both groups. At last follow-up, the KSS (p 0.014)
and function score (p 0.001) were signiﬁcantly better in the 2SR
group than in the DPRA group. Regarding walking aids, in the
DPRA group, ten patients (25.7%) did not require aid, 15 pa-
tients (38.5%) needed a cane, three patients (7.7%) needed two
canes, nine patients (23.0%) needed a walker, and two patients
(5.1%) were unable to walk. In the 2SR group, four patients
(16.0%) did not require aid, 18 patients (72.0%) needed a cane,
and three patients (12.0%) needed a walker. When this variable
was categorized into independent mobility (no cane, or one
cane) and restricted mobility (two canes, walker, or unable),
the independent mobility rates were 64.1% in the DPRA group,
and 88.0% in the 2SR group (p 0.031).
Radiological ﬁndings
At last follow-up, there were radiolucent lines in three patients
in the DPRA group, and in one patient in the 2SR group. All
radiolucent lines were present around the tibial componentTABLE 5. Functional outcomes
DPRA 2SR p
KSS knee, mean (SD)
Preoperative 42.2 (13.3) 44.6 (11.1) 0.351
Postoperative 65.0 (14.5) 73.5 (10.5) 0.014
KSS function, mean (SD)
Preoperative 28.5 (16.1) 31.1 (16.8) 0.484
Postoperative 45.3 (24.6) 63.6 (14.3) 0.001
ROM, mean (SD)
Preoperative 91.8 (8.6) 93.2 (6.2) 0.502
Postoperativea 96.2 (12.9) 93.3 (6.7) 0.305
Knee status (n) 0.014
Mobile 28 19
Arthrodesis 11 1
DPRA, debridement with prosthesis retention and antibiotherapy; KSS, Knee
Society score; ROM, range of motion; SD, standard deviation; 2SR, two-stage
revision.
aKnees without arthrodesis.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infe(zones 3–4), lower than 2 mm, and non-progressive. Only the
two patients with chronic antibiotic suppression, one in each
group, had radiological evidence of tibial septic loosening. The
remaining patients in both groups had no signs of loosening.DiscussionThe most important clinical ﬁndings in our study were as fol-
lows: (a) effectiveness in controlling infection within 3 months
of arthroplasty with 2SR was signiﬁcantly higher than with
DPRA, (b) the failure risk was not associated with the duration
of symptoms (less than or greater than 4 weeks), and (c) the
only predictor of failure was the isolation of S. aureus or
S. epidermidis. Treatment with 2SR required fewer operations, a
lower duration of hospitalization, and a shorter duration of
treatment; also, the functional outcome was better at last
follow-up. All patients who required a second debridement
ultimately underwent prosthesis removal.
The high failure rate after DPRA in our study is consistent
with other recent reports [4,7]. A multicentre study reported a
failure rate of 69% after DPRA [21]. Conversely, other studies
reported failure rates after DPRA of only 15–19%, but
repeated debridement was not considered to be failure in these
reports [3,5,22]. According to our failure criterion, these series
would have reported failure rates between 41% and 65%.
Schoifet y Morrey [23] reported a failure rate of 77%, despite
the fact that the authors performed several additional de-
bridements. Regarding failures after 2SR, those studies with
>100 patients reported failure rates of 12–28% [24–26]. Sys-
tematic reviews found rates of 5–12% [9,27]. In comparative
studies, Choi et al. [12] reported failure rates of 69% afterctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e11–851.e17
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failure rates of 16% and 21%, respectively. Similarly to Sherrell
et al. [28], our success rate for subsequent 2SR after failed
DPRA was signiﬁcantly lower than for 2SR as the initial treat-
ment. Conversely, a prior DPRA did not inﬂuence the results of
a subsequent 2SR in other studies [25,29].
A duration of symptoms of >4 weeks has been suggested to
be a failure risk factor after DPRA [10,30,31]. However, other
studies reported a failure rate of 80% in those patients un-
dergoing DPRA in the ﬁrst 10 days after the index TKA [7,32].
Like other authors [4,5,7,29], we found no signiﬁcant difference
between the groups with regard to duration of symptoms.
The most common pathogens in the present study were
S. aureus and epidermidis (71.8%), and they were isolated from
81.5% of the failures, which is consistent with other recent
studies [5,7,31]. Fehring et al. [7] suggested that the higher
failure rate after DPRA could be due to the inability to
completely remove the bioﬁlm attached to the prosthesis,
because 80% of staphylococcal infections treated with DPRA
were not controlled, whereas 84% of those treated with 2SR
were controlled. As in our study, other authors found that
methicillin-resistant staphylococcal infections were not associ-
ated with an increased risk of treatment failure [25]. Several
other factors have been associated with the risk of treatment
failure, such as diabetes, rheumatoid arthritis, obesity, and
malignancy [27]. Like other recent studies [4,7,28], we did not
ﬁnd that patient-related factors were signiﬁcantly associated
with a higher failure rate.
The types of antibiotics administered and treatment duration
did not inﬂuence the failure rate. In addition, the administration
of rifampicin did not inﬂuence the failure rate. In contrast, other
authors found that the use of rifampicin could improve the
prognosis after DPRA in both methicillin-susceptible and
methicillin-resistant staphylococcal infections [8].
Functional outcomes after periprosthetic infection are
frequently absent in the literature, so it is difﬁcult to compare
treatments. In our study, the functional outcomes at last follow-
up were signiﬁcantly better in the 2SR group than in the DPRA
group, which was also reported in other study [4].
This study has several limitations. Patients were followed
prospectively, but data collection was performed in a retro-
spective manner. Another limitation of the study was its rela-
tively small size, owing to the low prevalence of the event. Our
minimum follow-up was 3 years, which could increase the
failure rate in the longer term, but recurrence of infection
rarely occurs after 2 years. The strength of the present study
was standardization of surgical procedures, antibiotic regimen,
and follow-up.
In conclusion, the present study found that debridement
with prosthetic retention for management of periprostheticClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectknee infection within 3 months of the index arthroplasty has a
high failure rate. Two-stage revision was superior to debride-
ment with respect to controlling infection, and it was also
associated with better functional outcomes. However, further
comparative studies are needed to conﬁrm these results.Transparency declarationThe authors declare that they have no conﬂicts of interest.References[1] Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections.
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